New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 27, 2013
12:35 EDTWHX, TIVO, DGIT, VHC, AMRNOptions with increasing implied volatility: WHX VHC TIVO AMRN DGIT
News For WHX;VHC;TIVO;AMRN;DGIT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 21, 2014
06:10 EDTTIVOTiVo November volatility elevated into Q3 and outlook
Subscribe for More Information
November 20, 2014
11:49 EDTVHCVirnetX updates licensing declarations to ETSI, ATIS
Subscribe for More Information
November 19, 2014
15:00 EDTAMRNStonepine Capital reports 5.2% passive stake in Amarin
November 17, 2014
09:06 EDTAMRNAmarin reports new data from MARINE, ANCHOR phase 3 studies
Amarin announced the presentation of new data and related analyses from the MARINE and ANCHOR phase 3 studies. The data show that use of Vascepa capsules significantly reduced remnant-like particle cholesterol, or RLP-C, levels -- a cardiovascular risk factor -- including significant placebo-adjusted reductions in RLP-C in studied patient populations with triglyceride, or TG, levels greater than or equal to 200 mg/dL and greater than or equal to 500 mg/dL, including patients that received statin therapy. The data were presented today by Dr. Christie M. Ballantyne as part of a moderated poster session at the American Heart Association Scientific Sessions in Chicago. Remnant-like particle cholesterol is an important emerging risk factor for cardiovascular disease and represents the cholesterol content of a subset of triglyceride-rich lipoproteins, or TRL, called remnants. In the fasting state this subset of TRLs is comprised of very low-density lipoproteins, or VLDL, and intermediate-density lipoproteins, or IDL, and in the non-fasting state includes these two types of lipoproteins together with chylomicron remnants.Elevated plasma TG levels are a marker of elevated remnant cholesterol and are associated with increased risk for cardiovascular disease.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use